Trial Profile
Pain Management in Osteoarthritis using the Centrally Acting Analgesics Duloxetine and Pregabalin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Acronyms DUPRO
- 13 Jun 2016 Status changed from recruiting to completed.
- 16 Dec 2015 Accrual to date is 97% according to United Kingdom Clinical Research Network record.
- 25 Nov 2015 New source identified and integrated- Clinicaltrials.gov